{"id":"https://genegraph.clinicalgenome.org/r/3bb8309a-2a22-4518-b352-9420638271c8v1.2","type":"EvidenceStrengthAssertion","dc:description":["*AP4M1* loss-of-function variants were first reported in relation to autosomal recessive Adaptor Protein 4 (AP4) deficiency syndrome in 2009 (PMID: 19559397). AP4 deficiency results in severe early-onset developmental delay with motor and speech delay, intellectual disability, hypotonia in infancy followed by spastic paraplegia and later tetraplegia, microcephaly, and seizures (PMID: 32979048). At least 59 individuals from 34 families with biallelic *AP4M1* nonsense, frameshift, splicing and large deletion variants leading to loss of protein function have been reported (PMIDs: 19559397, 24700674, 25496299, 29096665, 32979048). This gene-disease relationship is also supported by biochemical and functional evidence demonstrating loss of AP4 complex function and abnormal glutamate receptor GluRδ2 staining in dendrites of post-mortem brain samples from patients with *AP4M1* loss-of-function variants (PMID: 19559397).\n\nIn summary, there is definitive evidence supporting the relationship between *AP4M1* and autosomal recessive AP4 deficiency syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 7, 2021 (SOP Version 8).","AP4M1 loss-of-function variants were first reported in relation to autosomal recessive Adaptor Protein 4 (AP4) deficiency syndrome in 2009 (PMID: 19559397). AP4 deficiency results in severe early-onset developmental delay with motor and speech delay, intellectual disability, hypotonia in infancy followed by spastic paraplegia and later tetraplegia, microcephaly, and seizures (PMID: 32979048). At least 59 individuals from 34 families with biallelic AP4M1 nonsense, frameshift, splicing and large deletion variants leading to loss of protein function have been reported (PMIDs: 19559397, 24700674, 25496299, 29096665, 32979048). The gene-disease association is further supported by biochemical and functional evidence demonstrating loss of AP4 complex function and abnormal glutamate receptor GluRδ2 staining in dendrites of post-mortem brain samples from patients with AP4M1 loss-of-function variants (PMID: 19559397). In summary, the AP4M1 gene is definitively associated with autosomal recessive AP4 deficiency syndrome. This classification was approved by the ClinGen Intellectual Disability and Autism Working Group on 04/07/2021 (SOP Version 8)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3bb8309a-2a22-4518-b352-9420638271c8","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-08-18T15:17:46.902Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2021-04-06T22:00:00.000Z","2021-04-07T16:00:00.000Z"],"role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85001527-651e-41d2-a9ba-7be48d55c7ee_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85465fb3-9d99-4053-b819-bd7dd0f7df7c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700674","rdfs:label":"Tüysüz-Patient-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0001250","obo:HP_0001263","obo:HP_0000750","obo:HP_0001270","obo:HP_0001258"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/85001527-651e-41d2-a9ba-7be48d55c7ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700674","allele":{"id":"https://genegraph.clinicalgenome.org/r/6084fe77-3d71-46ec-b5bb-eb473345bcd6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004722.4(AP4M1):c.1012C>T (p.Arg338Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346965"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4ef5b786-bfb4-437c-8cf3-02b7dbeda0e8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1a25afe-2f66-463d-8ae1-b3cf37f8a24e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Patient92","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0000750","obo:HP_0001270","obo:HP_0000252","obo:HP_0001258","obo:HP_0001263"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4ef5b786-bfb4-437c-8cf3-02b7dbeda0e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/fe17ee87-2c75-4d73-a4a9-81f405115792","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000007.14:g.100106402G>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368474688"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/60c2153c-c1d5-48f4-8218-1b9183ed6908_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ea62074-e443-479f-9964-6a3e779de7ea","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Patient120","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0001258","obo:HP_0000750","obo:HP_0001270","obo:HP_0001250","obo:HP_0001263"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/60c2153c-c1d5-48f4-8218-1b9183ed6908_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/4866b96d-fd63-49f1-af17-59ebb584018e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004722.4(AP4M1):c.694del (p.Glu232LysfsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139770950"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e50befd8-857a-4e8e-8490-eff97a3d33e1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc7386fd-fb74-4e31-83a5-4236619c9fe4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Patient62","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0000750","obo:HP_0001250","obo:HP_0001258","obo:HP_0001263","obo:HP_0001270"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e50befd8-857a-4e8e-8490-eff97a3d33e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec84687d-5f24-4245-ae3e-83957f5960ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_005250689.4(AP4M1):c.1158+1G>T (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4374980"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d9fc75fc-1761-4f01-9ce2-2f84869d2e41_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60d97ae4-3fb8-4b91-8fa8-4d0e9ab9b07a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Patient124","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0001258","obo:HP_0001263","obo:HP_0000750","obo:HP_0000252","obo:HP_0001270"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d9fc75fc-1761-4f01-9ce2-2f84869d2e41_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/12e0f558-2215-4b66-aa4f-68ecbc42375b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004722.4(AP4M1):c.802C>T (p.Arg268Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4374799"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d0c1fb62-fafd-49e0-a568-51dc9c064875_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ec397c5-0a41-45a3-8293-569d488c7ef3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700674","rdfs:label":"Tüysüz-Patient-3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0001263","obo:HP_0001258","obo:HP_0000750","obo:HP_0001250","obo:HP_0001270"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0c1fb62-fafd-49e0-a568-51dc9c064875_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700674","allele":{"id":"https://genegraph.clinicalgenome.org/r/419ba856-65b9-4b9d-8776-f681cfc29db9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004722.4(AP4M1):c.952C>T (p.Arg318Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249973"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dadb138d-1f7b-46ac-a37b-60baf45888e2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Family41","family":{"id":"https://genegraph.clinicalgenome.org/r/dadb138d-1f7b-46ac-a37b-60baf45888e2","type":"Family","rdfs:label":"Family41","member":{"id":"https://genegraph.clinicalgenome.org/r/1ebc934b-0410-40c5-a2f1-9ff556404d0e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Patient69","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":12,"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001270","obo:HP_0001258","obo:HP_0001250","obo:HP_0001263","obo:HP_0000750"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9da4c33a-d331-46a1-b7b5-3fa430b1237c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/b6b39a82-0807-44ba-a9f9-07309f0db5db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004722.4(AP4M1):c.916C>T (p.Arg306Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/561150"}},"paternityMaternityConfirmed":"none"}}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001250","obo:HP_0001270","obo:HP_0000750","obo:HP_0001263","obo:HP_0001258"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1ebc934b-0410-40c5-a2f1-9ff556404d0e"}},{"id":"https://genegraph.clinicalgenome.org/r/1183b272-6113-48cc-99cd-ab15b71e9234_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Family78","family":{"id":"https://genegraph.clinicalgenome.org/r/1183b272-6113-48cc-99cd-ab15b71e9234","type":"Family","rdfs:label":"Family78","member":{"id":"https://genegraph.clinicalgenome.org/r/60d97ae4-3fb8-4b91-8fa8-4d0e9ab9b07a"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000252","obo:HP_0001258","obo:HP_0001263","obo:HP_0001270","obo:HP_0000750","obo:HP_0001250"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/60d97ae4-3fb8-4b91-8fa8-4d0e9ab9b07a"}},{"id":"https://genegraph.clinicalgenome.org/r/8eaabfa2-8cb9-42a5-b60d-33174c3e16e8_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29096665","rdfs:label":"Bettencourt-Family","estimatedLodScore":1.45,"family":{"id":"https://genegraph.clinicalgenome.org/r/8eaabfa2-8cb9-42a5-b60d-33174c3e16e8","type":"Family","rdfs:label":"Bettencourt-Family"},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0000750"},{"id":"obo:HP_0001250"},{"id":"obo:HP_0001258"},{"id":"obo:HP_0001263"},{"id":"obo:HP_0001270"}],"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/19b4e864-66bd-440e-b90d-4e43906c9486_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700674","rdfs:label":"Tüysüz-Family2","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/19b4e864-66bd-440e-b90d-4e43906c9486","type":"Family","rdfs:label":"Tüysüz-Family2","member":{"id":"https://genegraph.clinicalgenome.org/r/2ec397c5-0a41-45a3-8293-569d488c7ef3"}},"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001250","obo:HP_0000750","obo:HP_0001263","obo:HP_0001270","obo:HP_0001258"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2ec397c5-0a41-45a3-8293-569d488c7ef3"}},{"id":"https://genegraph.clinicalgenome.org/r/3fd5539f-f7af-477f-998c-607072c6aaf3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19559397","rdfs:label":"Verkerk-Moroccan-Family","estimatedLodScore":3.16,"family":{"id":"https://genegraph.clinicalgenome.org/r/3fd5539f-f7af-477f-998c-607072c6aaf3","type":"Family","rdfs:label":"Verkerk-Moroccan-Family","member":{"id":"https://genegraph.clinicalgenome.org/r/77b78610-ff40-4a8a-9d53-f5541eecae35","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19559397","rdfs:label":"IV-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":24,"detectionMethod":"Linkage/homozygosity mapping identified 14 Mb candidate region on chromosome 7q22 containing 203 genes. \n\nmRNA expression of candidate gene transcripts in fibroblasts from probands and controls identified the AP4M1 gene as the strongest downregulated transcript in all neurologically compromised patients with a 2-fold downregulation of the gene (Figure S2).\n\nSequencing of the AP4M1 candidate locus revealed a splice donor site homozygous mutation in intron 14, c.1137+1G→T, in all five patients, whereas the parents were heterozygous (Figure 3A). ","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0001263","obo:HP_0000252","obo:HP_0000750","obo:HP_0001258","obo:HP_0001270"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f99f6143-396d-4195-9e85-27ce3fbc3caa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19559397","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec84687d-5f24-4245-ae3e-83957f5960ea"},"paternityMaternityConfirmed":"none"}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001258","obo:HP_0000252","obo:HP_0001263","obo:HP_0000750","obo:HP_0001270"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/77b78610-ff40-4a8a-9d53-f5541eecae35"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e798ef88-d090-4995-ae35-10c61e4e4ee0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25496299","rdfs:label":"Jameel-AP4M1","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/e798ef88-d090-4995-ae35-10c61e4e4ee0","type":"Family","rdfs:label":"Jameel-AP4M1","member":{"id":"https://genegraph.clinicalgenome.org/r/b7aa9c3f-fdd3-4cfc-aa09-d73c80c1310b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25496299","rdfs:label":"IV3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"detectionMethod":"Whole exome sequencing (WES) was performed on 50 ng of genomic DNA from the two affected brothers","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001258","obo:HP_0000252","obo:HP_0000750","obo:HP_0001263","obo:HP_0001270"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2beaff29-70da-4cf7-af8b-0f2941154978_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25496299","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b1f10f0-9e09-4a1a-a6f4-3bf5aaaa55f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004722.4(AP4M1):c.194_195del (p.Tyr65PhefsTer50)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139770958"}},"paternityMaternityConfirmed":"none"}}},"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001258","obo:HP_0001263","obo:HP_0001270","obo:HP_0000252","obo:HP_0000750"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b7aa9c3f-fdd3-4cfc-aa09-d73c80c1310b"}},{"id":"https://genegraph.clinicalgenome.org/r/9448bc9e-70e8-4ee6-a3c6-1536907f0861_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24700674","rdfs:label":"Tüysüz-Family1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/9448bc9e-70e8-4ee6-a3c6-1536907f0861","type":"Family","rdfs:label":"Tüysüz-Family1","member":{"id":"https://genegraph.clinicalgenome.org/r/85465fb3-9d99-4053-b819-bd7dd0f7df7c"}},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001263","obo:HP_0000750","obo:HP_0001270","obo:HP_0001250","obo:HP_0001258"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/85465fb3-9d99-4053-b819-bd7dd0f7df7c"}},{"id":"https://genegraph.clinicalgenome.org/r/733e9798-9fb0-409b-a6a2-e35a37430ab6_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Family36","family":{"id":"https://genegraph.clinicalgenome.org/r/733e9798-9fb0-409b-a6a2-e35a37430ab6","type":"Family","rdfs:label":"Family36","member":{"id":"https://genegraph.clinicalgenome.org/r/cc7386fd-fb74-4e31-83a5-4236619c9fe4"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001250","obo:HP_0001270","obo:HP_0001258","obo:HP_0001263","obo:HP_0000750","obo:HP_0000252"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cc7386fd-fb74-4e31-83a5-4236619c9fe4"}},{"id":"https://genegraph.clinicalgenome.org/r/eacbcb46-5b88-4598-b32a-b19a9d1234ed_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"Family76","family":{"id":"https://genegraph.clinicalgenome.org/r/eacbcb46-5b88-4598-b32a-b19a9d1234ed","type":"Family","rdfs:label":"Family76","member":{"id":"https://genegraph.clinicalgenome.org/r/2ea62074-e443-479f-9964-6a3e779de7ea"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001270","obo:HP_0001258","obo:HP_0001250","obo:HP_0000750","obo:HP_0000252","obo:HP_0001263"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2ea62074-e443-479f-9964-6a3e779de7ea"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9da4c33a-d331-46a1-b7b5-3fa430b1237c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ebc934b-0410-40c5-a2f1-9ff556404d0e"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2beaff29-70da-4cf7-af8b-0f2941154978_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7aa9c3f-fdd3-4cfc-aa09-d73c80c1310b"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f99f6143-396d-4195-9e85-27ce3fbc3caa_proband_score_evidence_line","type":"EvidenceLine","dc:description":"2 points were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V8) for each case was too high and allowed for too few (only 4) cases to reach a definitive classification for AR conditions.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77b78610-ff40-4a8a-9d53-f5541eecae35"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1d26ff1-be98-45be-a8fe-5ed66a984f86","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4b5b336-bf76-474c-a2c7-93e32ec55de2","type":"Finding","dc:description":"mu subunit (μ4; encoded by AP4M1) of AP-4 interacted directly and specifically with δ2 receptor in the yeast two-hybrid system","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14572453","rdfs:label":"μ4-δ2 receptor yeast two-hybrid system interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7660aff1-0ebf-4790-9fac-82417ffe44cf","type":"EvidenceLine","dc:description":"The finding that all four AP4 subunits result in a very similar, distinct phenotype is very strong evidence; this also demonstrates biochemical functional evidence of the involvement of AP4E1 in  the AP4 complex","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f976e80-44ba-4750-b280-1fccd2047485","type":"Finding","dc:description":"AP4B1, AP4E1 and AP4S1 also encode the three other subunits of the adaptor protein 4 (AP4); loss of any of these subunits results in the same AP4 deficiency clinical phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"AP4 protein function","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f49be3e4-4e1f-478b-b4e0-f41623e5b548_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66a116e0-2f94-4b57-8f8f-a32a4470ba8c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ce1625c-5ea4-4be6-8cf2-25186d0fff2a","type":"FunctionalAlteration","dc:description":"Patient post-mortem brain immunohistochemistry showed abnormal staining of glutamate receptor GluRδ2 in the Purkinje cell perikaryal and structural changes in dendritic arborization of Purkinje cells –  suggestive of abnormal vesicle-mediated transport to the dendrites and retention at the trans-Golgi network","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19559397","rdfs:label":"Abnormal GluRδ2 patterning in patient dendrites"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":11309,"specifiedBy":"GeneValidityCriteria8","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/hHk53SA3CYI","type":"GeneValidityProposition","disease":"obo:MONDO_0100176","gene":"hgnc:574","modeOfInheritance":"obo:HP_0000007"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f49be3e4-4e1f-478b-b4e0-f41623e5b548-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}